NCT04652310

Brief Summary

Fractures of the upper part of the femur may be treated with intramedullary nails. There are different designs to choose from. The intention of this RCT is to compare two nails with some of the same properties, but with different lengths. Usually, it is the surgeon who decides which nail to be used. The literature indicates that there is a lack of good evidence in the decision-making, and that the choice often depends on personal preferences and experience of the surgeon. Therefore, the investigators want to compare whether one of the nails has a better outcome than the other, and in that way be able to give some clearer guidelines for treatment. Patients will be randomized into two groups, one receiving a long nail and one receiving an extended-short nail and compare surgical and functional outcomes. Information from the operation and subsequent check-ups will be analysed. The hypothesis is that the extended-short nail can reduce operating time, bleeding, fluoroscopy time and give equal or better functional outcome, without increasing reoperation rates or mortality.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2020

Completed
5 days until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 3, 2020

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 29, 2024

Status Verified

May 1, 2024

Enrollment Period

3.9 years

First QC Date

November 26, 2020

Last Update Submit

May 27, 2024

Conditions

Keywords

intramedullary nailingTFNA

Outcome Measures

Primary Outcomes (1)

  • Difference in Short Physical Performance Battery (SPPB)-score

    Short Physical Performance Battery (SPPB)-score, ranges from 0-12, 12 is the best indicating a good physical function.

    At 3 months and 1 year

Secondary Outcomes (9)

  • Difference in Operation time

    Surgery date

  • Difference in Blood loss

    Surgery date

  • Difference in Harris Hip score

    3 months and 1 year

  • Difference in EQ5D-5L (EuroQoL 5L - health-related quality of life)

    3 months and 1 year

  • Difference in Transfusion after surgery

    2 weeks after surgery

  • +4 more secondary outcomes

Study Arms (2)

Extended-Short Nail

ACTIVE COMPARATOR

Implantation of TFNA extended-short nail (235 mm)

Device: TFNA extended-short nail (235 mm)

Long nail

ACTIVE COMPARATOR

Implantation of TFNA long nail (260-480 mm)

Device: TFNA long nail (260-480mm)

Interventions

The extended short version of the TFN-advanced proximal femoral nailing system (TFNA)

Also known as: TFN-advanced proximal femoral nailing system (TFNA) 235 mm
Extended-Short Nail

The long version of the TFN-advanced proximal femoral nailing system (TFNA)

Also known as: TFN-advanced proximal femoral nailing system (TFNA) 260-480mm
Long nail

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Intertrochanteric, pertrochanteric or subtrochanteric fractures
  • Distal fracture limit within 4 cm below the trochanter minor
  • Intramedullary nailing with TFNA-nail is indicated
  • Patient is fit for surgery.

You may not qualify if:

  • AO 31-A3 fractures (revers oblique fractures)
  • Cognitively impaired patients who themselves cannot understand the study information and give informed consent, and do not have a next of kin or legal guardian who can give consent on their behalf.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Drammen Hospital, Vestre Viken HF

Drammen, 3004, Norway

RECRUITING

Kongsberg hospital, Vestre Viken HF

Kongsberg, 3612, Norway

RECRUITING

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Heidi B Dyrop, MD, PHD

    Orthopedic Dpt, Kongsberg Hospital, Vestre Viken HF

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Heidi B Dyrop, MD, PHD

CONTACT

Andreas Stangeby, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2020

First Posted

December 3, 2020

Study Start

December 1, 2020

Primary Completion

November 1, 2024

Study Completion

December 1, 2025

Last Updated

May 29, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations